drugset / Trial / NCT00695188

Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis

NCT00695188 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective is to determine whether erythrocyte polyglutamate levels are associated with objective clinical response in patients with rheumatoid arthritis after oral administration of low-dose methotrexate.The secondary aim of this study is to compare the efficacy and safety of standard dose methotrexate versus a higher starting dose.

Timeline

Start
2008-05
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule 15 mg Oral
Comparator Methotrexate Small molecule 20 mg Oral
Comparator Methotrexate Small molecule 25 mg Oral

Indications